VR-CAP Regimen

Preferred Label : VR-CAP Regimen;

NCIt synonyms : Bortezomib/Cyclophosphamide/Doxorubicin/Prednisone/Rituximab; Bortezomib-Cyclophosphamide-Doxorubicin-Prednisone-Rituximab; Bortezomib/Rituximab/Cyclophosphamide/Doxorubicin/Prednisone; Bortezomib/Cyclophosphamide/Doxorubicin/Prednisone/Rituximab Regimen; Bortezomib-Cyclophosphamide-Doxorubicin-Prednisone-Rituximab Regimen; Bortezomib/Cyclophosphamide/Doxorubicin/Prednisone Plus Rituximab; Velcade/Rituxan-Cyclophosphamide/Adriamycin/Prednisone;

NCIt related terms : VR-CAP;

NCIt definition : A regimen consisting of bortezomib, cyclophosphamide, doxorubicin, prednisone and rituximab that can be used for the treatment of mantle cell lymphoma.;

NCI Metathesaurus CUI : CL1664727;

Codes from synonyms : 24552;

Details

Origin ID

C181653;

UMLS CUI

C5557198;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Bortezomib [NCIt concept]
- Cyclophosphamide [NCIt concept]
- Doxorubicin [NCIt concept]
- Prednisone [NCIt concept]
- Rituximab [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients